Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.

Kirkitadze MD, Bitan G, Teplow DB.

J Neurosci Res. 2002 Sep 1;69(5):567-77. Review.

PMID:
12210822
[PubMed - indexed for MEDLINE]
2.

Beta-amyloid, neuronal death and Alzheimer's disease.

Carter J, Lippa CF.

Curr Mol Med. 2001 Dec;1(6):733-7. Review.

PMID:
11899259
[PubMed - indexed for MEDLINE]
3.

Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease.

Klein WL, Stine WB Jr, Teplow DB.

Neurobiol Aging. 2004 May-Jun;25(5):569-80. Review.

PMID:
15172732
[PubMed - indexed for MEDLINE]
4.

Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses.

Cerpa W, Dinamarca MC, Inestrosa NC.

Curr Alzheimer Res. 2008 Jun;5(3):233-43. Review.

PMID:
18537540
[PubMed - indexed for MEDLINE]
5.

Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.

Conway KA, Baxter EW, Felsenstein KM, Reitz AB.

Curr Pharm Des. 2003;9(6):427-47. Review.

PMID:
12570807
[PubMed - indexed for MEDLINE]
6.

Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Yamin G, Ono K, Inayathullah M, Teplow DB.

Curr Pharm Des. 2008;14(30):3231-46. Review.

PMID:
19075703
[PubMed - indexed for MEDLINE]
7.

Always around, never the same: pathways of amyloid beta induced neurodegeneration throughout the pathogenic cascade of Alzheimer's disease.

Hoozemans JJ, Chafekar SM, Baas F, Eikelenboom P, Scheper W.

Curr Med Chem. 2006;13(22):2599-605. Review.

PMID:
17017913
[PubMed - indexed for MEDLINE]
8.

Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease.

Thal DR, Griffin WS, Braak H.

J Cell Mol Med. 2008 Oct;12(5B):1848-62. doi: 10.1111/j.1582-4934.2008.00411.x. Epub 2008 Jul 10. Review.

PMID:
18624777
[PubMed - indexed for MEDLINE]
9.

Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.

Butterfield DA.

Free Radic Res. 2002 Dec;36(12):1307-13. Review.

PMID:
12607822
[PubMed - indexed for MEDLINE]
10.

Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.

Pereira C, Agostinho P, Moreira PI, Cardoso SM, Oliveira CR.

Curr Drug Targets CNS Neurol Disord. 2005 Aug;4(4):383-403. Review.

PMID:
16101556
[PubMed - indexed for MEDLINE]
11.

Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.

Kirkitadze MD, Kowalska A.

Acta Biochim Pol. 2005;52(2):417-23. Epub 2005 May 31. Review.

PMID:
15933761
[PubMed - indexed for MEDLINE]
Free Article
12.

Production of reactive oxygen species from aggregating proteins implicated in Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.

Tabner BJ, Turnbull S, El-Agnaf O, Allsop D.

Curr Top Med Chem. 2001 Dec;1(6):507-17. Review.

PMID:
11895127
[PubMed - indexed for MEDLINE]
13.

Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.

Götz J, Schild A, Hoerndli F, Pennanen L.

Int J Dev Neurosci. 2004 Nov;22(7):453-65. Review.

PMID:
15465275
[PubMed - indexed for MEDLINE]
14.

Clusterin and Alzheimer's disease.

Calero M, Rostagno A, Frangione B, Ghiso J.

Subcell Biochem. 2005;38:273-98. Review.

PMID:
15709484
[PubMed - indexed for MEDLINE]
15.

Neuroprotective approaches in experimental models of beta-amyloid neurotoxicity: relevance to Alzheimer's disease.

Harkany T, Hortobágyi T, Sasvári M, Kónya C, Penke B, Luiten PG, Nyakas C.

Prog Neuropsychopharmacol Biol Psychiatry. 1999 Aug;23(6):963-1008. Review.

PMID:
10621945
[PubMed - indexed for MEDLINE]
16.

Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer's disease.

Standridge JB.

Curr Alzheimer Res. 2006 Apr;3(2):95-108. Review.

PMID:
16611010
[PubMed - indexed for MEDLINE]
17.

Amyloid binding ligands as Alzheimer's disease therapies.

Lee VM.

Neurobiol Aging. 2002 Nov-Dec;23(6):1039-42. Review.

PMID:
12470800
[PubMed - indexed for MEDLINE]
18.

Abeta aggregation and possible implications in Alzheimer's disease pathogenesis.

Bharadwaj PR, Dubey AK, Masters CL, Martins RN, Macreadie IG.

J Cell Mol Med. 2009 Mar;13(3):412-21. doi: 10.1111/j.1582-4934.2009.00609.x. Review.

PMID:
19374683
[PubMed - indexed for MEDLINE]
19.

Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.

Giménez-Llort L, Blázquez G, Cañete T, Johansson B, Oddo S, Tobeña A, LaFerla FM, Fernández-Teruel A.

Neurosci Biobehav Rev. 2007;31(1):125-47. Epub 2006 Oct 20. Review.

PMID:
17055579
[PubMed - indexed for MEDLINE]
20.

Amyloid associated proteins in Alzheimer's and prion disease.

Veerhuis R, Boshuizen RS, Familian A.

Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):235-48. Review.

PMID:
15975027
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk